ANO1 suppresses tumor cell ferroptosis by regulating the PI3K‒Akt signaling axis, promoting the production and secretion of TGF-β by cancer cells to recruit CAFs, and conferring immunotherapeutic resistance [40]. Here, TGFB1 is linked to neoplasm.